Serum and urinary levels of tumor necrosis factor-alpha and interferon-gamma in diabetic nephropathy patients: a systematic review

被引:1
|
作者
Flake, Chastene Christopher [1 ]
Aguas, Imoan Shallom [1 ]
Policarpio, Archie [1 ]
Ysais, Angelanna [1 ]
Tiongco, Raphael Enrique [1 ]
Navarro, Annalyn [1 ]
机构
[1] Angeles Univ Fdn, Coll Allied Med Profess, Dept Med Technol, Angeles City 2009, Philippines
关键词
Tumor necrosis factor-alpha; Interferon-gamma; Inflammatory cytokines; Diabetic nephropathy; Urine; Systematic review; TNF-ALPHA; OXIDATIVE STRESS; INFLAMMATION; PROGRESSION; CYTOKINES; DISEASE; INTERLEUKIN-1; BIOMARKERS; MARKERS; DAMAGE;
D O I
10.1007/s13410-023-01280-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveIn this systematic review, we determined the association of selected inflammatory cytokines in blood and urine with diabetic nephropathy (DN).MethodsA literature search using the key terms "tumor necrosis factor-alpha," "interferon-gamma," and "diabetic nephropathy" was conducted in PubMed from December 2020 to January 2021. Relevant findings from these studies were collated for qualitative synthesis.ResultsBased on the synthesis of results, TNF-alpha and IFN-gamma levels were consistently higher among DN patients than T2DM patients with no renal complications and healthy individuals. A negative correlation with the estimated glomerular filtration rate (eGFR) and a positive correlation with the albumin-to-creatinine ratio (ACR) were also noted by most studies which assessed their relationship with renal markers.ConclusionThe findings of this systematic review suggest the association of serum and urinary TNF-alpha and IFN-gamma levels with diabetic nephropathy. However, further studies must be conducted to confirm these findings.
引用
收藏
页码:644 / 651
页数:8
相关论文
共 50 条
  • [21] Promoter attenuation in gene therapy: Interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression
    Qin, LH
    Ding, YZ
    Pahud, DR
    Chang, E
    Imperiale, MJ
    Bromberg, JS
    HUMAN GENE THERAPY, 1997, 8 (17) : 2019 - 2029
  • [22] MODULATION OF THE GROWTH OF TRANSFORMED-CELLS BY HUMAN-TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA
    LEWIS, GD
    AGGARWAL, BB
    EESSALU, TE
    SUGARMAN, BJ
    SHEPARD, HM
    CANCER RESEARCH, 1987, 47 (20) : 5382 - 5385
  • [23] Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma
    Kasama, Tsuyoshi
    Isozaki, Takeo
    Odai, Tsuyoshi
    Matsunawa, Mizuho
    Wakabayashi, Kuninobij
    Takeuchi, Hiroko T.
    Matsukura, Satoshi
    Adachi, Mitsuru
    Tezuka, Masakazu
    Kobayashi, Kazuo
    TRANSLATIONAL RESEARCH, 2007, 149 (05) : 265 - 273
  • [24] INTERFERON-GAMMA AND TUMOR NECROSIS FACTOR-ALPHA - USE IN GRAM-NEGATIVE INFECTION AFTER SHOCK
    MALANGONI, MA
    LIVINGSTON, DH
    SONNENFELD, G
    POLK, HC
    ARCHIVES OF SURGERY, 1990, 125 (04) : 444 - 446
  • [25] INVITRO ANTI-HUMAN IMMUNODEFICIENCY VIRUS ACTIVITIES OF TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA
    WONG, GHW
    KROWKA, JF
    STITES, DP
    GOEDDEL, DV
    JOURNAL OF IMMUNOLOGY, 1988, 140 (01): : 120 - 124
  • [26] Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages
    Malaguarnera, L
    Musumeci, M
    Di Rosa, M
    Scuto, A
    Musumeci, S
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2005, 19 (03) : 128 - 132
  • [27] EFFECT OF INTERLEUKIN-2, INTERFERON-GAMMA, AND MITOGENS ON THE PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND FACTOR-BETA
    NEDWIN, GE
    SVEDERSKY, LP
    BRINGMAN, TS
    PALLADINO, MA
    GOEDDEL, DV
    JOURNAL OF IMMUNOLOGY, 1985, 135 (04): : 2492 - 2497
  • [28] INTERFERON-GAMMA RELEASE ASSAYS IN RHEUMATIC PATIENTS: BASELINE STUDY AND IN THE COURSE OF ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS
    Martinez-Morillo, M.
    Minguez, S.
    Mateo, L.
    Latorre, I.
    Dominguez, J.
    Grados, D.
    Tejera, B.
    Riveros, A.
    Holgado, S.
    Olive, A.
    Tena, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 277 - 277
  • [29] Augmented procoagulant activity in cancer patients, treated with recombinant interferon-gamma in addition to recombinant tumor necrosis factor-alpha and melphalan
    Mulder, AB
    Zwaveling, JH
    Smid, WM
    Maring, JK
    vanGinkel, RJ
    Girbes, ARJ
    Koops, HS
    vanderMeer, J
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (06) : 897 - 901
  • [30] PHASE-I STUDY OF A COMBINATION OF RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA AND RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS
    KURZROCK, R
    FEINBERG, B
    TALPAZ, M
    SAKS, S
    GUTTERMAN, JU
    JOURNAL OF INTERFERON RESEARCH, 1989, 9 (04): : 435 - 444